Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00577694 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped funding unavailable

Conditions

Leukemia

Interventions

DRUG: clofarabine
DRUG: gemtuzumab ozogamicin

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]